Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved sector : Professional, scientific, and technical services save search
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
Published: 2024-04-17 (Crawled : 15:00) - globenewswire.com
MOLN | $3.67 -3.42% -3.54% 320
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
approved meeting molecular
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
PBLA | $1.15 -6.31% 360K
|
Professional, Scientific, and T...
|
| O: 29.1%
H: 177.92%
C: 71.16%
approval therapeutics
Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition
Published: 2023-11-08 (Crawled : 17:00) - globenewswire.com
EQRX | $2.34 2.14% 17M
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.26%
C: -2.09%
RVMD S | $35.81 -2.74% -2.82% 1M
|
Health Technology
|
| O: 0.37%
H: 1.07%
C: -1.81%
acquisition
Endonovo's SofPulse® Secures Taiwan FDA Approval
Published: 2023-10-12 (Crawled : 13:00) - globenewswire.com
ENDV | $0.0024 158.07% 350K
|
Professional, Scientific, and T...
|
| O: 22.0%
H: 0.0%
C: -11.48%
sofpulse fda approval
Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
Published: 2023-09-12 (Crawled : 13:30) - globenewswire.com
GANX | $3.15 -0.94% -0.95% 78K
|
Professional, Scientific, and T...
|
| O: 4.37%
H: 2.98%
C: -4.71%
gt-0228 australia approval research therapeutics study
BriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholders
Published: 2023-08-25 (Crawled : 19:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
approval therapeutics
LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis
Published: 2023-07-26 (Crawled : 12:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 5.0%
H: 4.29%
C: -2.38%
fda approval treatment pharmaceuticals
Quince Therapeutics to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
Published: 2023-07-24 (Crawled : 12:20) - biospace.com/
QNCX | $1.055 5.5% 5.21% 81K
|
Professional, Scientific, and T...
|
| O: -5.7%
H: 0.0%
C: -22.82%
sales approved acquire therapeutics
ACG Acquisition notes Brazil antitrust approval for mines acquisition – Morningstar
Published: 2023-07-06 (Crawled : 13:00) - spacfeed.com
EFSH 4 | $1.82 -1.62% -4.95% 180K
|
Professional, Scientific, and T...
|
| O: -0.62%
H: 0.0%
C: -7.7%
approval acquisition brazil
ACG Acquisition notes Brazil antitrust approval for mines acquisition – Marketscreener.com
Published: 2023-07-06 (Crawled : 12:00) - spacfeed.com
EFSH 4 | $1.82 -1.62% -4.95% 180K
|
Professional, Scientific, and T...
|
| O: -0.62%
H: 0.0%
C: -7.7%
approval acquisition brazil
FDA Approves BriaCell’s Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer
Published: 2023-06-27 (Crawled : 12:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 4.15%
H: 0.29%
C: -11.65%
fda breast cancer study
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
Published: 2023-06-26 (Crawled : 20:00) - globenewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.12%
H: 0.41%
C: 0.41%
IRWD | $7.59 -0.78% -0.79% 3.6M
|
Health Technology
|
| O: 0.0%
H: 0.47%
C: -0.56%
approved meeting
LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in Singapore
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 1.66%
H: 1.91%
C: -9.39%
camzyos approval
LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 10.09%
C: 0.92%
camzyos approval china
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
Published: 2023-05-01 (Crawled : 14:00) - biospace.com/
BMEA | $11.18 -2.78% -2.86% 1.7M
|
Professional, Scientific, and T...
|
| O: 0.54%
H: 9.38%
C: 7.02%
bmf-500 fda drug clearance application leukemia
TransCode Therapeutics Announces IRB Approval for FDA Cleared First-In-Human Clinical Trial
Published: 2023-04-27 (Crawled : 11:00) - globenewswire.com
RNAZ | $0.5195 3.59% 3.46% 270K
|
Professional, Scientific, and T...
|
| O: 16.22%
H: 3.49%
C: -22.26%
fda cleared approval trial therapeutics
Molecular Partners Announces Shareholders Approve All Board Proposals at the Annual General Meeting
Published: 2023-04-04 (Crawled : 16:00) - globenewswire.com
MOLN | $3.67 -3.42% -3.54% 320
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
meeting molecular
Dominari Financial Granted Approval to Acquire Broker Dealer
Published: 2023-03-21 (Crawled : 21:00) - prnewswire.com
DOMH | $2.77 -1.07% -1.08% 11K
|
Professional, Scientific, and T...
|
| O: -1.53%
H: 4.35%
C: -7.45%
granted approval acquire financial
Healthcare Integrated Technologies, Inc. Announces Approval of U.S. Patent for Fall Validation with Privacy-Aware Monitoring System
Published: 2023-03-17 (Crawled : 14:00) - globenewswire.com
HITC | $0.097 70.77% 14K
|
Professional, Scientific, and T...
|
| O: 3.27%
H: 5.23%
C: 2.0%
patent approval system
BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100
Published: 2023-03-13 (Crawled : 12:00) - biospace.com/
BRTX | $1.435 3.24% 3.14% 250K
|
Professional, Scientific, and T...
|
| O: -2.65%
H: 5.44%
C: 5.44%
brtx-100 fda application approval
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.